Yao Fei, Yuan Qin, Yan Yichao, Liang Guoqiang, Zhou Liang, Xu Heng, Gao Shaomei, Zou Ting, Zhang Lurong
Central Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, Jiangsu, China.
Clinical Pharmaceutical Laboratory of Traditional Chinese Medicine, Suzhou Academy of Wumen Chinese Medicine, Suzhou, 215000, Jiangsu, China.
Sci Rep. 2024 Dec 28;14(1):31522. doi: 10.1038/s41598-024-83197-7.
Yu-Ping-Feng-San (YPF) is a famous classical Chinese medicine formula known for its ability to boost immunity. YPF has been applied to enhance the immune status of tumor patients in clinical practice. However, there is still a lack of research on its immune regulatory effects and mechanisms in the tumor microenvironment. This study was designed to investigate the effects and mechanism of YPF on improving the immune suppression state of hepatocellular carcinoma (HCC) microenvironment. In an orthotopic mouse model of HCC, YPF improved the immune microenvironment of HCC immunosuppression, enhanced the maturation of dendritic cells (DCs), promoted the release of IL-12, and decreased the presence of JAK2, p-JAK2, STAT3, and p-STAT3 proteins in both tumor tissue and paracancerous tissues. YPF also could promote the maturation and reduce the activation of JAK2, p-JAK2, STAT3, and p-STAT3 proteins of mouse bone marrow-derived DCs induced by culture medium or tumor supernatant in vitro. Transient transfection of siRNA-STAT3 with DCs resulted in an increase in its maturation and its secretion of IL-12. On the whole, these combined effects of YPF served to ameliorate the HCC immune suppression microenvironment, which conducive to immune cells play the role of immune surveillance and killing liver cancer cells. The mechanisms of these combined effects were, at least in part, related to its inhibition of the activated JAK2-STAT3 signaling pathway in DCs within the HCC microenvironment.
玉屏风散(YPF)是一种著名的经典中药方剂,以其增强免疫力的能力而闻名。YPF已在临床实践中用于提高肿瘤患者的免疫状态。然而,关于其在肿瘤微环境中的免疫调节作用和机制仍缺乏研究。本研究旨在探讨YPF改善肝细胞癌(HCC)微环境免疫抑制状态的作用及机制。在HCC原位小鼠模型中,YPF改善了HCC免疫抑制的免疫微环境,增强了树突状细胞(DCs)的成熟,促进了IL-12的释放,并降低了肿瘤组织和癌旁组织中JAK2、p-JAK2、STAT3和p-STAT3蛋白的表达。YPF还可以促进体外培养基或肿瘤上清液诱导的小鼠骨髓来源DCs的成熟,并降低JAK2、p-JAK2、STAT3和p-STAT3蛋白的激活。用DCs瞬时转染siRNA-STAT3导致其成熟及IL-12分泌增加。总体而言,YPF的这些联合作用有助于改善HCC免疫抑制微环境,有利于免疫细胞发挥免疫监视和杀伤肝癌细胞的作用。这些联合作用的机制至少部分与其抑制HCC微环境中DCs内激活的JAK2-STAT3信号通路有关。
Recent Pat Anticancer Drug Discov. 2025
J Ethnopharmacol. 2024-7-15
J Exp Clin Cancer Res. 2020-11-25
Front Pharmacol. 2024-8-5
Medicine (Baltimore). 2024-5-3
World J Gastroenterol. 2022-12-7
Nat Rev Gastroenterol Hepatol. 2023-4